U.S. stock indexes slipped on Thursday after three straight days of gains following positive updates on the Omicron coronavirus variant, with focus now turning towards economic data for clues on the Federal Reserve's policy decision.
U.S. stock indexes were set to fall on Thursday after logging three straight days of gains on positive updates on the Omicron coronavirus variant, with focus now turning towards economic data for clues on the Federal Reserve's policy decision.
Major companies using Amazon.com's data services got a painful lesson this week about how the complexity and market dominance of the company's cloud unit make it difficult to back up their data with other providers, analysts and experts told Reuters.
With the extreme volatility the market has been seeing recently, you're not alone if you've seen your basket of stocks fluctuate or plunge on some particularly choppy market days. But does that mean you should sell your stocks? Not so fast. In this segment of Backstage Pass, reco
U.S. stock indexes were set to fall on Thursday after logging three straight days of gains on positive updates on the Omicron coronavirus variant, with focus now turning towards economic data for clues on the Federal Reserve's policy decision.
While some stock prices have been beaten-down lately, others are soaring toward historical highs. If you're evaluating some of your favorite stocks right now and think they look overpriced, you're not alone. But price should never be the sole factor guiding your stock-buying deci
People are quitting their jobs right and left, and this trend doesn't appear to be anywhere close to dying down. In this segment of Backstage Pass, recorded on Nov. 15, Motley Fool contributors Jason Hall, Toby Bordelon, and Rachel Warren discuss some of the push factors driving
Recently, Citizens Financial Group (NYSE: CFG), a $187 billion asset large regional bank based in Rhode Island, announced that it plans to extend its point-of-sale, buy-now-pay-later (BNPL) relationship with Microsoft (NASDAQ: MSFT). BNPL has been all the rage lately, with compan
Meta Platforms (NASDAQ: FB), formerly known as Facebook, could soon open retail stores as it expands upon its vision to dominate the metaverse. In this segment of Backstage Pass, recorded on Nov. 5, Fool contributors Toby Bordelon, Vicki Hutchison, and Rachel Warren discuss wheth
Regardless of what's happening with the market, dividend stocks can be a great way to boost your overall portfolio returns and generate extra investing capital. In this segment of Backstage Pass, recorded on Nov. 12, Fool contributors Toby Bordelon, Rachel Warren, and Jon Quast r
Are These Good Tech Stocks To Invest In Now?Tech stocks appear to be a key focus of investors in the latest stock market hot streak. This is apparent as the tech-heavy Nasdaq index has mostly recovered from the Omicron variant-related sell-offs over the Thanksgiving weekend. Over
U.S. stock indexes struggled for direction on Wednesday after a strong start to the week, as investors digested a fresh update on Pfizer and BioNTech's COVID-19 vaccine, while the fast-spreading Omicron variant kept bigger bets in check.
Key Takeaways CFRA believes cyclical sectors will outperform more defensive sectors in early 2022. This week, we upgraded the Energy and Information Technology sectors to Overweight recommendations, with Chevron (CVX), Exxon Mobil (XOM), Apple (AAPL), and Microsoft (MSFT) among our favored large-cap stocks within the sectors. CFRA also has favorable ratings on Vanguard Energy ETF [...] Read more at ETFtrends.com.
Apple Inc is within striking distance of a $3 trillion market capitalization, a milestone that would make it as big as the world's fifth largest economy after Germany, just over a year after breaching the $2 trillion mark.
Apple Inc is within striking distance of a $3 trillion market capitalization, a milestone that would make it as big as the world's fifth largest economy after Germany, just over a year after breaching the $2 trillion mark.
U.S. stocks struggled for direction in volatile trading on Wednesday as investors digested a fresh update on Pfizer and BioNTech's COVID-19 vaccine, while the fast-spreading Omicron variant kept bigger bets in check.
U.S. stock index futures edged higher on Wednesday after Pfizer and BioNTech said a three-shot course of their COVID-19 vaccine was shown to have a neutralizing effect against the new Omicron coronavirus variant in a laboratory test.